Viking Therapeutics (VKTX) Tops Q4 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Constellation Brands (STZ) Tops Q1 EPS by 18c
• Trump's annual disclosures show $236 million in crypto proceeds, gifts worth $370,000
• Horizon Bancorp faces $3M jury verdict in auto repossession case